Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach

By afschroeder • April 25, 2026

Idossa D, Hennessy MA, LeVee A, Nanda R, McArthur H, Leon-Ferre RA. Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach. Am Soc Clin Oncol Educ Book. 2026 Jun;46(3):e520666. doi: 10.1200/EDBK-26-520666. Epub 2026 Apr 24. PMID: 42030501.

Tags: Hematology/Oncology, Publications

Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2

Muñoz J, Locke FL, Reagan PM, Goy A, Jacobson CA, Hill BT, Timmerman JM, Flinn IW, Miklos DB, Pagel JM, Kersten MJ, Forcade E, Topp[...]

Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care System

Wu JT, Lin N, Adams SV, Asch S, Zeliadt S, Harris AHS, Han SS, Backhus L. Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for[...]

Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study results

Hochman MJ, Ruppert AS, Huang Y, Mims A, Borate U, Swords R, Traer E, Baer MR, Duong VH, Stock W, Odenike T, Patel P, Madanat[...]